Tesamorelin Visceral Fat Reduction

Tesamorelin 5mg Research Peptide is a GHRH analog. It stimulates the pituitary gland to release endogenous Growth Hormone (GH) [25]. Unlike GH itself, Tesamorelin is specifically researched for its ability to reduce excess visceral fat. This is the deep fat surrounding internal organs. It does this without significantly affecting subcutaneous fat [26]. This makes it a valuable compound for studying metabolic function, obesity, and lipodystrophy models.

The 5 mg dosage is provided for researchers investigating metabolic function, lean muscle preservation, and cognitive health in various models. Studies are also evaluating its potential as a therapy for insulin resistance, obesity, and nonalcoholic fatty liver disease (NAFLD) [27]. **For research use only. Not for human consumption.** This product is strictly for laboratory and research purposes. All researchers must adhere to local and institutional guidelines when handling this compound. The targeted action of **Tesamorelin 5mg Research Peptide** on visceral fat makes it a unique and important tool for advanced metabolic and endocrinology research. It is a key compound for fat reduction studies.